Q&A with Dr. Sofija Jovic

February 7, 2019

Increasingly, sponsors are turning to experts who have “been there, done that” to help them develop protocols for their CNS trials. In this wide-ranging interview, Sofija Jovic, PhD, MBA, of WCG MedAvanteProPhase, explains why this is the case. She also discusses, among other topics, how clinical trial metrics haven’t always kept pace with scientific innovation.

Previous Flipbook
SNAPSI: Bridging the Gap Between Research and Clinical Care in Mental Health
SNAPSI: Bridging the Gap Between Research and Clinical Care in Mental Health

In the field of mental health, there is a discrepancy between how research is conducted and how care is del...

Next Flipbook
Q&A with CNS Expert, Dr. Leo Verhagen Metman
Q&A with CNS Expert, Dr. Leo Verhagen Metman

Leo Verhagen Metman, a member of WCG’s Scientific Leadership Team, shared his insights during a recent conv...

Request a Genetics in Clinical Trials training session

What You'll Learn